Mycio Wealth Partners LLC bought a new stake in UnitedHealth Group Inc (NYSE:UNH) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 4,474 shares of the healthcare conglomerate’s stock, valued at approximately $1,092,000.

Other large investors have also recently modified their holdings of the company. Geode Capital Management LLC grew its stake in shares of UnitedHealth Group by 9.1% in the fourth quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock valued at $2,882,988,000 after buying an additional 965,763 shares in the last quarter. Founders Financial Securities LLC boosted its holdings in UnitedHealth Group by 17.1% in the fourth quarter. Founders Financial Securities LLC now owns 1,446 shares of the healthcare conglomerate’s stock valued at $360,000 after purchasing an additional 211 shares during the last quarter. Partner Investment Management L.P. boosted its holdings in UnitedHealth Group by 5.3% in the fourth quarter. Partner Investment Management L.P. now owns 4,654 shares of the healthcare conglomerate’s stock valued at $1,159,000 after purchasing an additional 234 shares during the last quarter. Partner Fund Management L.P. boosted its holdings in UnitedHealth Group by 6.7% in the fourth quarter. Partner Fund Management L.P. now owns 240,885 shares of the healthcare conglomerate’s stock valued at $60,009,000 after purchasing an additional 15,092 shares during the last quarter. Finally, First Foundation Advisors boosted its holdings in UnitedHealth Group by 12.2% in the fourth quarter. First Foundation Advisors now owns 11,663 shares of the healthcare conglomerate’s stock valued at $2,905,000 after purchasing an additional 1,268 shares during the last quarter. Institutional investors and hedge funds own 85.37% of the company’s stock.

A number of research analysts recently commented on UNH shares. Royal Bank of Canada set a $311.00 price target on UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. Morgan Stanley increased their price target on UnitedHealth Group from $285.00 to $298.00 and gave the company an “overweight” rating in a report on Friday, July 12th. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a report on Monday, July 15th. Citigroup raised UnitedHealth Group from a “neutral” rating to a “buy” rating and increased their price target for the company from $247.00 to $280.00 in a report on Friday, May 10th. Finally, Raymond James increased their price target on UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a report on Friday, July 19th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have issued a buy rating to the company. UnitedHealth Group presently has an average rating of “Buy” and an average target price of $295.06.

In related news, Director William C. Ballard, Jr. sold 12,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total value of $3,063,720.00. Following the sale, the director now owns 61,309 shares of the company’s stock, valued at approximately $15,652,800.79. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $248.00, for a total value of $2,480,000.00. Following the completion of the sale, the director now directly owns 187,663 shares in the company, valued at approximately $46,540,424. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 37,000 shares of company stock worth $9,195,620. 0.82% of the stock is currently owned by company insiders.

NYSE:UNH traded up $0.35 during trading hours on Wednesday, reaching $240.51. 1,450,874 shares of the stock were exchanged, compared to its average volume of 3,223,414. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. The firm has a 50 day simple moving average of $251.34 and a 200-day simple moving average of $247.54. UnitedHealth Group Inc has a 52 week low of $208.07 and a 52 week high of $287.94. The stock has a market capitalization of $232.84 billion, a P/E ratio of 18.67, a P/E/G ratio of 1.31 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, topping analysts’ consensus estimates of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The company had revenue of $60.60 billion for the quarter, compared to the consensus estimate of $60.59 billion. During the same quarter last year, the business posted $3.14 EPS. UnitedHealth Group’s quarterly revenue was up 8.0% compared to the same quarter last year. As a group, analysts expect that UnitedHealth Group Inc will post 14.84 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a yield of 1.80%. The ex-dividend date of this dividend is Friday, September 13th. UnitedHealth Group’s dividend payout ratio is presently 33.54%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: Leveraged Buyout (LBO) Explained

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.